I earned my master's degree from Capital Medical University, where my research focused on exploring biomarkers to predict the efficacy of immune checkpoint inhibitors therapy for colorectal cancer.

 

CIMR, a newly established research and development institution, provides a state-of-the-art scientific platform that, combined with the excellent affiliated hospitals of Capital Medical University, allows me to better integrate experimental medicine with clinical practice and facilitate the translation of research outcomes into clinical applications.

 

My research interests lie in investigating the tumor immune microenvironment and immunotherapy, intending to enhance the application and efficacy of immunotherapy in cancer treatment and thereby improve the prognosis of cancer patients.

 

I hope that in 10 years, I will still be deeply engaged in this field and have become a new type of clinical doctor who seamlessly combines experimental medicine with clinical practice.